GADD45B and prostate carcinoma: Studies have shown that GADD45B is considered a prognostic and predictive biomarker in colorectal cancer (Zhao et al., 2018) and that increased levels of GADD45B predict improved survival of prostate cancer patients (Huang et al., 2018).